Abivax Chief Executive Marc de Garidel dismissed as "noise" reports in the French press that pharmaceutical giant Eli Lilly ...

A case targeting alleged fraud around the safety risk of a blockbuster diabetes drug is leveraging the RICO pathway and could ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

OUTBREAK ANNIVERSARY — Today marks one year since the strain of measles that spurred an outbreak in West Texas in 2025 was ...

Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...

Through its Genentech subsidiary, the pharmaceutical company promises to further the Triangle's bona fides as a GLP-1 hotspot ...

In an interview with BioPharma Dive, the veteran biotech CEO said there remains a “significant opportunity” for young ...

The latest uptick comes after French publication La Lettre reported that AstraZeneca (NASDAQ:AZN) is preparing a potential offer of €176 per share, valuing Abivax at approximately €13.75 billion. This ...

GSK's RAPT Therapeutics acquisition will strengthen the former's immunology pipeline – specifically its offerings for food ...